What is contract manufacturing in pharma?

Pharmaceutical contract manufacturing is the production of an active pharmaceutical ingredient (API), drug intermediate, or finished drug product by a third party on behalf of a sponsor that holds the regulatory marketing authorization. The contract manufacturer (CMO) or contract development and manufacturing organization (CDMO) operates the facility, manages the production process, and is typically responsible for current Good Manufacturing Practice (cGMP) compliance for the manufacturing steps it performs.

The legal relationship is governed by a Master Service Agreement (MSA) or Manufacturing and Supply Agreement that allocates regulatory responsibility, quality oversight, intellectual property, indemnity, and insurance obligations between sponsor and manufacturer. The MSA insurance section is typically the most heavily negotiated commercial clause and often arrives with sponsor demands that exceed what the manufacturer's baseline general liability program covers.

In Texas, contract manufacturers serving pharmaceutical sponsors typically need a specialty insurance program built around products liability, professional liability, recall coverage, cyber, property with cGMP validation extension, and D&O for the operating entity. Generic light-manufacturing programs almost never satisfy sponsor MSA insurance schedules on a strict reading.